PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3SC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,570
Award facts
- Contract value 100% obligated
- $32,570.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 19, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $32,570.07 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). This firm fixed-price delivery order, which will be performed in Conshohocken, Pennsylvania, represents a child contract with an ultimate completion date of January 20, 2026. The award utilized no set-aside designation, indicating the contract was competitively awarded on a full and open basis. AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through comprehensive delivery of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply a vast range of products to support military healthcare programs worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The underlying IDC reflects DLA's strategic approach to pharmaceutical procurement and supports customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2D826FA3SC?
SPE2D826FA3SC was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FA3SC worth?
The government has obligated $32,570 on SPE2D826FA3SC.
Is contract SPE2D826FA3SC an order under another contract?
Yes. SPE2D826FA3SC is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3SC competed?
The extent of competition for SPE2D826FA3SC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award